tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:AGN Stock Latest News

Insignia Financial Alters Stake in Argenica Therapeutics
Company AnnouncementsInsignia Financial Alters Stake in Argenica Therapeutics
9d ago
AGN
Argenica Therapeutics Advances Stroke Treatment Trials and Secures Funding
PremiumCompany Announcements
Argenica Therapeutics Advances Stroke Treatment Trials and Secures Funding
9d ago
AGN
Argenica Therapeutics Issues New Shares Following Option Exercise
PremiumCompany Announcements
Argenica Therapeutics Issues New Shares Following Option Exercise
23d ago
AGN
Argenica Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Argenica Therapeutics Lists New Securities on ASX
23d ago
AGN
Argenica Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Argenica Therapeutics Announces Cessation of Securities
23d ago
AGN
Argenica Therapeutics Expands ASX Quotation with New Securities
PremiumCompany AnnouncementsArgenica Therapeutics Expands ASX Quotation with New Securities
23d ago
AGN
Argenica Secures $1.5M Funding for Stroke Therapeutic Trials
Premium
Company Announcements
Argenica Secures $1.5M Funding for Stroke Therapeutic Trials
1M ago
AGN
Argenica Faces FDA Hold on US Stroke Trial Application
Premium
Company Announcements
Argenica Faces FDA Hold on US Stroke Trial Application
2M ago
AGN
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Progress
PremiumCompany Announcements
Argenica Therapeutics to Host Investor Webinar on Phase 2 Stroke Trial Progress
2M ago
AGN
Argenica Therapeutics Releases Investor Presentation Highlighting Future Plans
PremiumCompany Announcements
Argenica Therapeutics Releases Investor Presentation Highlighting Future Plans
2M ago
AGN
Argenica Therapeutics Advances Phase 2 Trial for Stroke Treatment
PremiumCompany Announcements
Argenica Therapeutics Advances Phase 2 Trial for Stroke Treatment
3M ago
AGN
Argenica Completes Dosing in Phase 2 Stroke Trial for ARG-007
PremiumCompany Announcements
Argenica Completes Dosing in Phase 2 Stroke Trial for ARG-007
4M ago
AGN
Argenica Therapeutics Announces Cessation of Securities
PremiumCompany AnnouncementsArgenica Therapeutics Announces Cessation of Securities
4M ago
AGN
Argenica Therapeutics Unveils Strategic Plans at Euroz Hartley’s Conference
Premium
Company Announcements
Argenica Therapeutics Unveils Strategic Plans at Euroz Hartley’s Conference
5M ago
AGN
Argenica Therapeutics Announces Director Departure
Premium
Company Announcements
Argenica Therapeutics Announces Director Departure
5M ago
AGN
Argenica Therapeutics Announces Director Resignation
PremiumCompany Announcements
Argenica Therapeutics Announces Director Resignation
5M ago
AGN
Argenica Therapeutics Reports Reduced Losses Amid Increased R&D Costs
PremiumCompany Announcements
Argenica Therapeutics Reports Reduced Losses Amid Increased R&D Costs
6M ago
AGN
Argenica’s ARG-007 Demonstrates Key Neuroprotective Effects in TBI Study
PremiumCompany Announcements
Argenica’s ARG-007 Demonstrates Key Neuroprotective Effects in TBI Study
6M ago
AGN
Argenica Therapeutics Reports Promising Results for TBI Treatment
PremiumCompany Announcements
Argenica Therapeutics Reports Promising Results for TBI Treatment
6M ago
AGN
Argenica’s Phase 2 Stroke Trial Proceeds with Positive Safety Review
PremiumCompany AnnouncementsArgenica’s Phase 2 Stroke Trial Proceeds with Positive Safety Review
6M ago
AGN
Argenica Therapeutics Advances Stroke Trial Progress
Premium
Company Announcements
Argenica Therapeutics Advances Stroke Trial Progress
8M ago
AGN
Argenica Therapeutics Advances Phase 2 Stroke Trial
Premium
Company Announcements
Argenica Therapeutics Advances Phase 2 Stroke Trial
9M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >